Low Brain Norepinephrine Levels in ME/CFS and Long COVID Pt. II: A ChatGPT Based Treatment Program
Check out how ChatGPT thinks people with ME/CFS and long COVID might treat the low norepinephine brain findings in these diseases.
Immune Dysregulation Could be the Tipping Point for Long COVID
Profound immune dysregulation could be the tipping point that turns a COVID-19 patient into a long COVID patient.
Stymied, Moving Forward or Both? The Long-COVID (and ME/CFS) Clinical Trials Dilemma
Big pharma is largely staying clear of long COVID trials but the many small and some quite large clinical trials are underway provide hope.
Nalmefene: Has Jarred Younger Discovered a Better LDN + an LDN / Rapamycin Osteoporesis Connection
Nalmefene may work better than low-dose naltrexone in ME/CFS, fibromyalgia, and long COVID, plus LDN and Rapamycin may help with osteoporosis.
Simmaron’s Rapamycin ME/CFS Trial Moves Forward: The Goal – FDA Approval
A successful rapamycin clinical trial in chronic fatigue syndrome (ME/CFS) leads to more studies and perhaps FDA approvalStudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
